Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Masahiro TodaMasato FujiokaYukina MorimotoKentaro OharaKenzo KosugiYumiko OishiMizuto SatoRyo UedaHirokazu FujiwaraTetsuro HikichiShinobu NojiNaoki OishiKaoru OgawaYutaka KawakamiTakayuki OhiraKazunari YoshidaMasahiro TodaPublished in: Nature communications (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.